Fernandes, Ian
Funakoshi, Shunsuke http://orcid.org/0000-0003-1146-4022
Hamidzada, Homaira http://orcid.org/0000-0003-0151-9608
Epelman, Slava http://orcid.org/0000-0003-3400-4475
Keller, Gordon http://orcid.org/0000-0001-9309-9297
Funding for this research was provided by:
Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (FDN159937)
Article History
Received: 13 November 2022
Accepted: 6 November 2023
First Online: 11 December 2023
Competing interests
: G.M.K. is a scientific co-founder and paid consultant for BlueRock Therapeutics LP, a paid consultant for VistaGen Therapeutics and a board member of Anagenesis Biotechnologies. All other authors declare no competing interests.